Aileron Therapeutics Stock (NASDAQ: ALRN) stock price, news, charts, stock research, profile.
You can purchase shares of Aileron Therapeutics (NASDAQ:ALRN) through any online brokerage.
Other companies in Aileron Therapeutics’s space includes: Renovaro (NASDAQ:RENB), CytomX Therapeutics (NASDAQ:CTMX), Cellectar Biosciences (NASDAQ:CLRB), Armata Pharmaceuticals (AMEX:ARMP) and Citius Oncology (NASDAQ:CTOR).
Aileron Therapeutics has a consensus price target of $10.00.
The stock price for Aileron Therapeutics (NASDAQ: ALRN) is $3.65 last updated October 31, 2024 at 8:33 AM EDT.
There are no upcoming dividends for Aileron Therapeutics.
Aileron Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Aileron Therapeutics.
Aileron Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.